532523:BOM
Biocon Ltd
₹367.90
arrow_downward
-0.03%(-0.10) 1D
Nov 11, 3:30:05 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 532523...
Open
₹370.40
High
₹373.65
Low
₹367.40
Mkt. cap
440.84B
Avg. vol.
197.96K
Volume
64.66K
Dividend
0.14%
Quarterly dividend
₹0.13
Ex-dividend date
Jul 3, 2026
P/E ratio
123.55
52-wk high
₹447.00
52-wk low
₹318.50
EPS
₹2.98
Shares outstanding
600.00M
No. of employees
16K
Open
₹370.40
High
₹373.65
Low
₹367.40
Mkt. cap
440.84B
Avg. vol.
197.96K
Volume
64.66K
Dividend
0.14%
Quarterly dividend
₹0.13
Ex-dividend date
Jul 3, 2026
P/E ratio
123.55
52-wk high
₹447.00
52-wk low
₹318.50
EPS
₹2.98
Shares outstanding
600.00M
No. of employees
16K
News stories
From web sources and news partners
Reuters
·
22 minutes ago
S&P 500, Nasdaq futures rise as CoreWeave results calm AI jitters
Yahoo Finance
·
1 hour ago
Spdr Dow Jones Industrial Average ETF (DIA) Buys $40.3 Million More GS on Nov. 9
WSJ
·
3 hours ago
Nasdaq Futures Rally as AI Optimism Returns
TradingView
·
1 hour ago
Mapping the Market: S&P 500 at risk of further losses
Profile
Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, with U.S. headquarters in Bridgewater, New Jersey. Founded by Kiran Mazumdar-Shaw in 1978 as a partner to the Irish brewing enzyme manufacturer Biocon Biochemicals Ltd., the company manufactures generic active pharmaceutical ingredients that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics, and branded drugs such as biosimilar insulins and antibodies for the Indian domestic market. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets.
Biocon's formulations for the Indian market include metabolics, oncology, immunotherapy, and nephrology products. Some of Biocon's key brands in India include INSUGEN, BASALOG, BIOMAb EGFR, BLISTO, CANMAb, Evertor, TACROGRAF, ALZUMAb and KRABEVA.
Syngene International Limited is a publicly listed subsidiary of Biocon, operating in the contract research and development organization. Wikipedia
About Biocon Ltd
CEOShreehas P Tambe
Employees16.4K
FoundedNov 29, 1978
HeadquartersBengaluru, Karnataka, India
SectorHealth Care
IndustryBiotechnology
Websitebiocon.com